Maltofer

Iron (III) ion, the active ingredient in Maltofer, is an iron supplement presented as an oral formulation for oral use. It is employed to treat iron deficiency anemia and to prevent iron deficiency in individuals at risk.

GNH USA supplies Maltofer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Clients benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the procurement process.

Maltofer is used in the management of iron‑related disorders, primarily addressing iron deficiency anemia and its prevention. - Iron deficiency anemia: restores hemoglobin levels and replenishes depleted iron stores. - Iron deficiency prevention: maintains adequate iron reserves in at‑risk populations such as children and women of reproductive age. - Chronic blood loss conditions: supports ongoing iron replacement to counteract losses from gastrointestinal bleeding or menstruation.

Oral iron supplementation may be associated with a range of adverse reactions, varying from mild gastrointestinal discomfort to rare severe events.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Constipation: reduced bowel movements and hard stools. - Abdominal discomfort: cramping or pain in the stomach area. - Darkened stools: black or tarry coloration without other symptoms. - Metallic taste: transient taste alteration in the mouth. - Diarrhea: loose stools occurring after dosing.

Serious or Rare Side Effects: - Hypersensitivity reactions: rash, itching, swelling, or anaphylaxis. - Iron overload: excessive accumulation leading to organ damage. - Severe gastrointestinal bleeding: persistent vomiting blood or melena. - Acute liver injury: elevated liver enzymes indicating hepatic stress.

Before initiating Maltofer therapy, several precautionary measures should be considered to ensure safe and effective use. - Assess iron status: confirm deficiency with laboratory tests before treatment. - Monitor hematology: regularly check hemoglobin and ferritin levels during therapy. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use cautiously in gastrointestinal disorders: patients with IBD or ulcer disease may experience exacerbated symptoms. - Separate from interfering agents: administer iron at least two hours apart from antacids, calcium supplements, or certain antibiotics. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Iron absorption can be affected by several concomitant medications and dietary substances, leading to clinically relevant interactions.

Major Interactions (Avoid): - Tetracycline antibiotics: chelation reduces antibiotic efficacy. - Oral phosphate binders: bind iron and markedly decrease its absorption. - Antacids containing aluminum or magnesium: impair iron uptake when taken together.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may lower gastric acidity and reduce iron absorption. - Vitamin C supplements: can increase iron absorption, potentially leading to excess. - Calcium‑rich foods or supplements: compete with iron for absorption pathways.